What You Should Know:
- Propeller Health announced
it will co-package a new asthma medication from Novartis, which was
approved by the European Commission this week for use in the EU.
- Enerzair®
Breezhaler® plus Propeller Health sensor is the first asthma medication to be
co-packaged and co-prescribed with a digital health platform.
- Propeller’s solution
works by attaching a sensor to the Enerzair® Breezhaler® inhaler, which then
delivers objective data on medication use to the
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Eliminating the Long, Cumbersome and Costly Diagnosis of Genetic Diseases
The answer to questions about human disease can be found in our genes. The difficulty in the past has been the testing process, a sort of trial and error approach of drilling down into the multitude of variants that can be found within the genes, variants that when analyzed in tandem with detailed clinical histories can actually tell the story and lead to a faster diagnosis.
Human beings carry around 20,000 genes and, of those, approximately 5,000 are somewhat understood, and those genes can
Read More
Verily, Cognizant Collaborate on Baseline COVID-19 Testing Program
What You Should Know:
- Cognizant has announced its collaboration with Verily
Life Sciences to facilitate and help increase easy and efficient COVID-19
testing across the U.S – which will be critical to ensuring the safety of
individuals going out and back to work as states reopen.
- Through this collaboration, Cognizant is providing a
team of its life sciences experts to support Verily’s Baseline COVID-19 Testing
Program to increase access to individuals needing to schedule COVID-19
Read More
BrightInsight Raises $40M for Regulated Digital Health Platform for Biopharma & Medtech
What You Should Know:
- BrightInsight, provider of the leading global regulated
digital health platform for biopharma and medtech, today announced a Series B
funding round of $40 million, led by global venture capital and private equity
firm, Insight Partners.
- Already the partner of choice to four global pharmaceutical leaders—AstraZeneca, Roche, CSL Behring, and Novo Nordisk—the Series B financing will enable BrightInsight to speed up hiring, expand its global footprint and add
Read More
Verily Launches Healthy at Work Program for COVID-19 Screening & Testing
What You Should Know:
- Verily launches Healthy at Work Program providing
ongoing COVID-19 screening and testing for a healthy return to work and school
to communities across the nation.
- The Healthy at Work program combines symptom screening, testing services, and data analytics. Employees, students, or others designated to participate in the program can use the online interface to record health symptoms each day.
Today, Verily, an Alphabet
company, has announced a new Healthy at
Read More
MD Anderson, Philips Partner on Personalized Oncology Treatments, Clinical Trial Matching
What You Should Know:
- Philips and MD Anderson collaborate to facilitate
personalized oncology treatments and clinical trial matching based on genomic
markers.
- Philips connects oncologists and pathologists around
the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of
actionable clinical information
Philips and The University of Texas MD Anderson Cancer
Center today announced a collaboration to provide oncologists with
evidence-based therapy and clinical
Read More
Foundation Medicine Acquires Precision Oncology Company Lexent Bio
What You Should Know:
- Foundation Medicine acquires Lexent Bio, a precision oncology company developing novel liquid biopsy platforms.
- The acquisition will accelerate Foundation Medicine’s liquid biopsy R&D and advance cancer care through an expansion of multiomics capabilities.
Foundation Medicine, Inc., announced that it has completed the acquisition
of Lexent Bio, Inc., a precision oncology
company located in California, developing novel multiomics liquid biopsy
platforms
Read More
Cue Health Lands $100M to Scale Rapid, Portable, Point-of-Care COVID-19 Test
What You Should Know:
- Cue Health raises $100M to commercialize its portable, molecular diagnostic test capable of detecting SARS-CoV-2, the virus that causes COVID-19, in less than 25 minutes using a simple nasal swab.
- The test is part of the Cue Health Monitoring System, which is designed to be a portable device that can perform a molecular test and connect patients to a mobile health platform that features interventional components such as telemedicine
Read More
COVID-19 Clinical Trials: How AI-Based Chatbots Can Provide Pandemic-Level Execution
More than 500 new COVID-19 related clinical trials have been registered as of the end of April. The race to find a COVID-19 vaccine is on and the public spotlight is on clinical trials. Strangely named drugs such as Hydroxychloroquine and Remdesivir have become household names and are featured and debated regularly on the 24-hour news channels.
The pressure to find a cure is intense. The locked-down world does not want to hear that at best, we may find a vaccine sometime in 2021. What
Read More
Intravacc, EpiVax Team Up in Development of COVID-19 Emerging Vaccine
What You Should Know:
- Combines Intravacc's unique OMV delivery platform with
synthetically produced COVID-19 epitopes from EpiVax' immunoinformatics toolbox
- Goal is to generate safe and effective adaptive
immunity against SARS-CoV-2 and related coronaviruses
- Clinical studies anticipated to start in Q4 2020
Intravacc, one
of the world's leading translational research and development vaccine
institutes, with an extensive track record in developing viral and
Read More
